Elizabeth A. Garofalo - Net Worth and Insider Trading

Elizabeth A. Garofalo Net Worth

The estimated net worth of Elizabeth A. Garofalo is at least $0 dollars as of 2024-11-10. Elizabeth A. Garofalo is the Director of Xenon Pharmaceuticals Inc and owns about 0 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $0. Details can be seen in Elizabeth A. Garofalo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elizabeth A. Garofalo has not made any transactions after 2024-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Elizabeth A. Garofalo

To

Elizabeth A. Garofalo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elizabeth A. Garofalo owns 4 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) , Xenon Pharmaceuticals Inc (XENE) , and Alector Inc (ALEC) among others .

Click here to see the complete history of Elizabeth A. Garofalo’s form 4 insider trades.

Insider Ownership Summary of Elizabeth A. Garofalo

Ticker Comapny Transaction Date Type of Owner
ACAD ACADIA Pharmaceuticals Inc 2020-09-29 director
XENE Xenon Pharmaceuticals Inc 2024-03-08 director
ALEC Alector Inc 2023-06-14 director
LIMIT LIMIT 2021-03-05 director

Elizabeth A. Garofalo Latest Holdings Summary

Elizabeth A. Garofalo currently owns a total of 1 stock. Elizabeth A. Garofalo owns 0 shares of Xenon Pharmaceuticals Inc (XENE) as of March 8, 2024, with a value of $0.

Latest Holdings of Elizabeth A. Garofalo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XENE Xenon Pharmaceuticals Inc 2024-03-08 0 45.00 0

Holding Weightings of Elizabeth A. Garofalo


Elizabeth A. Garofalo Form 4 Trading Tracker

According to the SEC Form 4 filings, Elizabeth A. Garofalo has made a total of 1 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 2,092 shares on March 8, 2024, which brought Elizabeth A. Garofalo around $95,584.

Insider Trading History of Elizabeth A. Garofalo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Elizabeth A. Garofalo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elizabeth A. Garofalo Ownership Network

Ownership Network List of Elizabeth A. Garofalo

No Data

Ownership Network Relation of Elizabeth A. Garofalo

Insider Network Chart

Elizabeth A. Garofalo Owned Company Details

What does ACADIA Pharmaceuticals Inc do?

Who are the key executives at ACADIA Pharmaceuticals Inc?

Elizabeth A. Garofalo is the director of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .

ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary

Over the past 18 months, Elizabeth A. Garofalo made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .

In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ACADIA Pharmaceuticals Inc Insider Transactions

No Available Data

Elizabeth A. Garofalo Mailing Address

Above is the net worth, insider trading, and ownership report for Elizabeth A. Garofalo. You might contact Elizabeth A. Garofalo via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.